FAM
BLTE

Fred Alger Management’s Belite Bio BLTE Stock Holding History

Fred Alger Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.98M Sell
62,574
-16,820
-21% -$2.83M 0.04% 168
2025
Q4 		$12.7M Buy
+79,394
New +$9.4M 0.05% 156

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fred Alger Management's BLTE Position: Q1 2026 in Review

Fred Alger Management reduced its Belite Bio (BLTE) stake by 21% in Q1 2026, selling an estimated $2.83M and leaving 62,574 shares worth $9.98M. The position accounts for 0.04% of the portfolio, ranked #168.

Fred Alger Management first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. The position peaked at $12.7M in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Fred Alger Management held 62,574 shares of Belite Bio worth $9.98M as of Q1 2026.
  • Fred Alger Management sold 16,820 Belite Bio shares in Q1 2026, an estimated $2.83M.
  • Belite Bio made up 0.04% of Fred Alger Management's portfolio in Q1 2026, its #168 holding.
  • Fred Alger Management first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
  • Fred Alger Management's Belite Bio position peaked at $12.7M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.